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A B S T R A C T
Background
Duration of use may be a modiﬁable risk factor for central venous catheter-associated bloodstream infection in newborn infants. Early
planned removal of peripherally inserted central catheters (PICCs) is recommended as a strategy to reduce the incidence of infection
and its associated morbidity and mortality.
Objectives
To determine the effectiveness of early planned removal of PICCs (up to two weeks after insertion) compared to an expectant approach
or a longer ﬁxed duration in preventing bloodstream infection and other complications in newborn infants.
Search methods
We searched of the Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 4), Ovid MEDLINE, Embase, Maternity
& Infant Care Database, and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (until April 2018), and
conference proceedings and previous reviews.
Selection criteria
Randomised and quasi-randomised controlled trials that assessed the effect of early planned removal of umbilical venous catheters (up
to two weeks after insertion) compared to an expectant management approach or a longer ﬁxed duration in preventing bloodstream
infection and other complications in newborn infants.
Data collection and analysis
Two review authors assessed trial eligibility independently. We planned to analyse any treatment effects in the individual trials and
report the risk ratio and risk difference for dichotomous data and mean difference for continuous data, with respective 95% conﬁdence
intervals. We planned to use a ﬁxed-effect model in meta-analyses and explore potential causes of heterogeneity in sensitivity analyses.
We planned to assess the quality of evidence for the main comparison at the outcome level using “Grading of Recommendations
Assessment, Development and Evaluation” (GRADE) methods.
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Main results
We did not identify any eligible randomised controlled trials.
Authors’ conclusions
There are no trial data to guide practice regarding early planned removal versus expectant management of PICCs in newborn infants.
A simple and pragmatic randomised controlled trial is needed to resolve the uncertainty about optimal management in this common
and important clinical dilemma.
P L A I N L A N G U A G E S U M M A R Y
Early planned removal versus expectant management of peripherally inserted central catheters to prevent infection in newborn
infants
Review question
In newborn infants with a peripherally inserted central catheter in place, does early removal of the catheter reduce the risk of compli-
cations, including infection?
Background
Infection in the bloodstream is a frequent and harmful complication for newborn infants who have a peripherally inserted central
catheter (a long, narrow, soft and ﬂexible plastic tube inserted through the skin into a vein and advanced several centimetres into the
infant’s large blood vessels; used as a stable route to deliver drugs and nutrition). Bloodstream infection may cause death and disability.
One potential method of reducing the risk of this and other serious complications is to remove the catheter within about two weeks
after insertion rather than leaving it for longer until no longer required.
Study characteristics/key results
We did not ﬁnd any randomised controlled trials that assessed whether removing peripherally inserted central catheters within two
weeks prevents infection or other complications in newborn infants.
Conclusions
There are no trial data available to help clinicians to address this common clinical dilemma. Due to the potential for beneﬁt and harm,
such a trial may be warranted.
B A C K G R O U N D
Description of the condition
Peripherally inserted central catheters (PICCs), also commonly re-
ferred to as percutaneous central venous catheters (CVCs), pro-
vide a stable route for the intravenous delivery of drugs or ﬂuids
to preterm or sick newborn infants. Typically, PICCs are inserted
via a superﬁcial vein in the upper or lower limb, usually avoiding
proximal sites such as the femoral or axillary veins, and are then
advanced so that the tip of the catheter is sited at the vena caval
junction with the right atrium of the heart (Jain 2013; Wrightson
2013). Peripherally inserted central catheters are less expensive and
easier to insert than catheters placed directly or via a subcutaneous
tunnel into central veins. Because they are more stable than short
peripheral cannulae, their use reduces the risk of extravasation in-
jury from hyperosmolar parenteral nutrition solutions and medi-
cations (Ainsworth 2015).
Bloodstream infection is the most common serious complication
associated with the use of PICCs in newborn infants. The re-
ported incidence ranges from about 2% to 30% depending on the
precise diagnostic criteria and the demographics of the popula-
tion studied (Chien 2002; Cartwright 2004; van der Zwet 2005;
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Garland 2008; Hoang 2008; Olsen 2009; O’Grady 2011; Ohki
2013). Very preterm infants are at the highest risk, but inter-unit
variation in the incidence of catheter-associated bloodstream in-
fection is not fully explained by case-mix and may relate to care
or infection control practices (Wong 2012). Newborn infants,
particularly very preterm infants, with an acquired bloodstream
infection have a higher risk of mortality and a range of impor-
tant morbidities including bronchopulmonary dysplasia, necro-
tising enterocolitis, retinopathy of prematurity, hepatic dysfunc-
tion and prolonged hospitalisation (Saint 2000; Mahieu 2001a;
Mahieu 2001b; Chapman 2003; Payne 2004; Adams-Chapman
2006;Hermans 2007; Lahra 2009). Bloodstream infection is asso-
ciated with higher rates of adverse neurodevelopmental outcomes
including cognitive or sensory impairment and cerebral palsy (Stoll
2004; Shah 2008a; Bassler 2009).
The most common causes of PICC-associated bloodstream in-
fections in newborn infants are coagulase-negative staphylococci,
other Gram-positive cocci (Staphylococcus aureus (S. aureus), ente-
rococci),Gram-negative bacilli and fungi (predominantlyCandida
species) (Makhoul 2002; O’Grady 2002; Stoll 2002; Isaacs 2003;
Isaacs 2004; Gordon 2006; de Brito 2010). Micro-organisms can
gain access through the PICC entry site or via the catheter hub
into the PICC lumen or tract. Pathogens adhere to the material
of the PICC and secrete an intraluminal or extraluminal bioﬁlm
of extracellular polymeric substances (Machado 2009). Bacteria
or fungi growing within the bioﬁlm are relatively protected from
the host’s immune system and circulating antimicrobial agents
thus enabling sustained colonisation (Ramirez de Arellano 1994;
Stewart 2001). It is often necessary to remove the PICC in order
to clear the infection (Benjamin 2001). A thrombus (blood clot)
attached to the PICC may be an additional nidus (locus) for in-
fection (Thornburg 2008). Some evidence exists that continuous
heparin infusion can reduce the incidence of PICC-occlusion in
neonates, but the data are insufﬁcient to determine the effect of
this intervention on the risk of infection (Shah 2008b).
Several strategies to prevent PICC-associated bloodstream infec-
tions have been developed and adopted, often as multifaceted
packages of interventions (’care bundles’). These include strict
aseptic precautions when inserting and accessing the PICC, use
of needleless intravascular catheter systems and prompt removal
when the PICC is no longer needed (O’Grady 2002; Yébenes
2004; Pronovost 2006; Borghesi 2008;Miller 2010; Sannoh 2010;
Vanholder 2010; Wirtschafter 2010; Kaplan 2011; O’Grady
2011; Schulman 2011). Care bundles have been shown to reduce
bloodstream infection rates in adult, paediatric and neonatal in-
tensive care studies (Pronovost 2006; Miller 2010; Wirtschafter
2010; Kaplan 2011; Schulman 2011; Fisher 2013). Despite these
strategies, however, PICC-associated infections remain a major
cause of morbidity and mortality in newborn infants and other
interventions are required to reduce the infection rates further.
Description of the intervention
Although strong associations between PICC exposure, especially
to deliver parenteral nutrition, and the risk of bloodstream infec-
tion have been described, observational studies have not provided
consistent evidence about the effect of duration of PICC place-
ment (’dwell time’) on the risk of invasive infection in newborn in-
fants. Some reports indicate an elevated risk of infection when the
PICC has been in place for more than about 10 to 14 days, while
others do not show any association until after a dwell time of four
to six weeks (Smith 2008; Sengupta 2010; Wong 2012; Milstone
2013; Greenberg 2015). Furthermore, it is not certain to what
extent PICC use is an independent risk factor for a bloodstream
infection or whether observed associations exist because infants
who are smaller, less mature, sicker and receiving more intensive
and invasive support are also more likely to have a PICC in situ. A
Cochrane review of randomised controlled trials of PICCs versus
peripheral cannulae for delivering parenteral nutrition to neonates
did not show an effect on invasive infection rates. Infants with a
PICCin situ experienced fewer skin break procedures than infants
with a peripheral cannula (or series of cannulae) and this may
have balanced the overall risk for acquiring bloodstream infection
(Ainsworth 2015).
This review examines the evidence from randomised controlled
trials that early planned removal within a pre-speciﬁed maximum
dwell time versus allowing clinicians to determine when the PICC
is removed or replaced affects the risk of bloodstream infection in
newborn infants. Limited guidance about this issue is available.
The 2011 USCenters for Disease Control and Prevention Health-
care Infection Control Practices Advisory Committee guidelines
do not specify a recommended maximum dwell time and advise
that PICCs should not be routinely replaced to prevent catheter-
related infections (O’Grady 2011). This uncertainty is reﬂected
in surveys of practice that identify wide variation between neona-
tal care centres with regard to PICC insertion and maintenance
(Sharpe 2013; Taylor 2014).
We deﬁne the maximum dwell time pragmatically as up to two
weeks after insertion based on the typical duration of PICC use
for infants in most neonatal units and the minimum time that
observational studies have shown this to be associated with a rise
in the risk of infection (Smith 2008; Sengupta 2010; Wong 2012;
Milstone 2013). The intervention is the pre-speciﬁed intent to
remove or replace the PICC within this time period, and the con-
trol is either (i) any permissive approach that does not pre-specify
dwell time but that allows PICC removal or replacement based
on clinical criteria (including suspected or conﬁrmed bloodstream
infection), or (ii) a longer pre-speciﬁed dwell time than the inter-
vention.
How the intervention might work
Pre-specifying a ﬁxedmaximum dwell time, with planned removal
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rather than an expectant approach, may reduce the risk of a PICC
being leftin situ when not actually in use or needed and reduce the
overall length of PICC exposure. These effects could lower the risk
of bloodstream infection and its associated complications if the
PICC is an independent risk factor for infection. This intervention
may also plausibly affect nutrient intake, either reducing receipt
of parenteral nutrients, or prompting a more rapid progression to
full enteral feeding, or both, with potential consequences for acute
morbidity (principally the risk of acute necrotising enterocolitis),
growth and development.
Why it is important to do this review
Given the potential for the planned duration of placement of
PICCs to affect important outcomes for newborn infants, we un-
dertook a systematic review to identify, appraise and synthesise the
available evidence from randomised controlled trials.
Related Cochrane reviews
Other Cochrane reviews assess the effects of other strategies in-
cluding antimicrobial impregnation or antibiotic locks to pre-
vent PICC-related infection in newborn infants, and early re-
moval versus expectant management of PICC in infants with
suspected bloodstream infection (Vasudevan 2011; Balain 2015;
Taylor 2015). Another review evaluates the evidence for short-
versus longer-term use of umbilical venous catheters for newborn
infants (Gordon 2016b).
O B J E C T I V E S
To determine the effectiveness of early planned removal of PICCs
(up to two weeks after insertion), compared to an expectant ap-
proach or a longer ﬁxed duration, in preventing infection in new-
born infants. We pre-speciﬁed subgroup analyses by gestational
age at birth (Subgroup analysis and investigation of heterogeneity).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised or quasi-randomised controlled trials, including clus-
ter-randomised controlled trials.
Types of participants
Newborn infants who are to have a PICC placed.
Types of interventions
• Intervention: early planned removal after ﬁxed-term use of
PICC (up to two weeks after insertion).
• Control: (i) permissive and expectant approach that allows
retention of PICC if needed and in the absence of clinical
indicators for removal or replacement, (ii) longer ﬁxed-term use
of PICC: at least one week longer than the intervention term.
Trials that assessed the effect of a pre-speciﬁed intendedduration of
PICC placement as part of a package of infection control measures
(care bundle) were eligible for inclusion but we planned to analyses
them separately from trials of discrete interventions.
We did not intend to include trials where the duration of PICC
use was related speciﬁcally to the infant’s progress in enteral feed
intake.
Types of outcome measures
Primary outcomes
• Incidence of laboratory-conﬁrmed bloodstream infection
conﬁrmed by culture from blood sampled from peripheral sites
(not from indwelling catheters) during hospital admission.
’False-positive’ results due to skin contaminants are possible,
therefore (where data were available), we planned to exclude
cases where infection was attributed to diphtheroids, micrococci,
Propionibacteriaceae or mixed microbial ﬂora. If sufﬁcient data
were available, we planned to examine speciﬁc infections with
these organisms:
◦ coagulase-negative staphylococci;
◦ other bacteria (Gram-negative bacilli, S. aureus,
enterococci);
◦ fungi.
Secondary outcomes
• Death before hospital discharge and up one year post-term
due to all causes.
• Neurodevelopmental outcomes assessed after 12 months
post-term using validated tools: neurological evaluations;
developmental scores; and classiﬁcations of disability, including
auditory and visual disability. We deﬁned neurodevelopmental
impairment as the presence of one or more of the following:
non-ambulant cerebral palsy; developmental quotient more than
two standard deviations below the population mean; and
blindness (visual acuity less than 6/60) or deafness (any hearing
impairment requiring or unimproved by ampliﬁcation).
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• Death or neurological impairment assessed after 12 months
post-term.
• Growth: time (days) to regain birth weight and average rate
of weight gain (g/kg/day), linear growth (mm/week), head
growth (mm/week) and skinfold thickness growth (mm/week)
during hospital admission.
• Extravasation injury: subcutaneous extravasation resulting
in skin ulceration; ’deep’ extravasation resulting in limb swelling;
or ’central’ extravasation-infusate in the pleural, peritoneal or
pericardial space.
• Number of cannulae or catheters used per infant to
administer parenteral ﬂuids until full enteral feeding established.
• Days to full enteral feeding.
• PICC leak, obstruction or breakage necessitating removal of
PICC.
• PICC-associated thrombosis necessitating removal of PICC.
• Other morbidity developing after enrolment in the trial
until discharge from hospital:
◦ bronchopulmonary dysplasia (oxygen
supplementation at 36 weeks postmenstrual age);
◦ necrotising enterocolitis (Bell stage 2 or 3);
◦ retinopathy of prematurity, requiring treatment
(medical or surgical).
Search methods for identification of studies
Weused the standard search strategy of CochraneNeonatal (http:/
/neonatal.cochrane.org/).
Electronic searches
We searched the Cochrane Central Register of Controlled Trials
(CENTRAL, 2018, issue 4), Ovid MEDLINE (1946 to April
2018), OVID Embase (1974 to April 2018), OVIDMaternity &
Infant Care Database (1971 to April 2018), and CINAHL (1982
to April 2018) using a combination of the text words and MeSH
terms described in Appendix 1. We limited the search outputs
with the relevant search ﬁlters for clinical trials as recommended
in the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011). We did not apply any language restrictions.
We searched ClinicalTrials.gov and the World Health Organiza-
tion’s International Trials Registry Platform (http://apps.who.int/
trialsearch/Default.aspx) for completed or ongoing trials.
Searching other resources
We examined reference lists in previous reviews and planned to
search the reference lists of any included studies. We searched the
proceedings of the annual meetings of the Pediatric Academic So-
cieties (1993 to 2017), the European Society for Pediatric Research
(1995 to 2017), the Royal College of Paediatrics and Child Health
(2000 to 2018) and the Perinatal Society of Australia and New
Zealand (2000 to 2018). Trials reported only as abstracts were
eligible if sufﬁcient information was available from the report, or
from contact with the authors, to fulﬁl the inclusion criteria.
Data collection and analysis
We used the standard methods of Cochrane Neonatal (http://
neonatal.cochrane.org/).
Selection of studies
We screened the title and abstract of all studies identiﬁed by the
above search strategy and two review authors (MG and WM) in-
dependently assessed the full-text articles for all potentially rele-
vant trials. We excluded those studies that did not meet all of the
inclusion criteria and stated the reason for exclusion. We planned
to discuss any disagreements with a third author (AG) until con-
sensus was achieved.
Data extraction and management
Two review authors (MG and WM) planned to extract data inde-
pendently using a data collection form to aid extraction of infor-
mation on design, methodology, participants, interventions, out-
comes and treatment effects from each included study.We planned
to discuss any disagreements until we reached a consensus. If data
from the trial reports were insufﬁcient, we planned to contact the
trialists for further information.
Assessment of risk of bias in included studies
We planned to make explicit judgements about whether studies
were at low, high, or unclear risk of bias across the domains sug-
gested in theCochrane Handbook for Systematic Reviews of Interven-
tions (Higgins 2011). We planned to assess the likely magnitude
and direction of the bias and whether we considered it is likely to
impact on the ﬁndings. We planned to explore the impact of the
level of bias in sensitivity analyses.
Measures of treatment effect
We planned to analyse the treatment effects in the individual tri-
als using Review Manager 5.3 (RevMan 2014) and report risk
ratio (RR) and risk difference (RD) for dichotomous data and
mean difference (MD) for continuous data, with respective 95%
conﬁdence intervals (CIs). We planned to determine the number
needed to treat for an additional beneﬁcial outcome (NNTB) or
an additional harmful outcome (NNTH) for analyses with a sta-
tistically signiﬁcant difference in the RD.We intended to conduct
intention-to-treat analyses.
5Early planned removal versus expectant management of peripherally inserted central catheters to prevent infection in newborn infants
(Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Unit of analysis issues
The intended unit of analysis was the participating infant in indi-
vidually-randomised trials and the neonatal unit (or sub-unit) for
cluster-randomised trials.
An infant would have been considered only once in an analysis.
We planned to exclude infants with multiple enrolments as we
would have been unable to address the associated unit of analysis
issues.
For cluster-randomised trials, we planned to undertake analyses at
the level of the individual while accounting for the clustering in the
data using the methods recommended in the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011).
Dealing with missing data
We planned to request additional data from the trialists if data on
important outcomes were missing or reported unclearly. Where
data were still missing, we planned to examine the impact on
effect size estimates in sensitivity analyses using the ’best-worst
case scenario’ technique.
Assessment of heterogeneity
We planned to examine the treatment effects of individual trials
and heterogeneity between trial results by inspecting the forest
plots. We planned to calculate the I² statistic for each RR analysis
to quantify inconsistency across studies and describe the percent-
age of variability in effect estimates that may be due to hetero-
geneity rather than to sampling error. If we detected moderate or
high heterogeneity (I² ≥ 50%), we planned to explore the possi-
ble causes (for example, differences in study design, participants,
interventions or completeness of outcome assessments).
Assessment of reporting biases
Had more than 10 trials been included in a meta-analysis, we
planned to examine a funnel plot for asymmetry.
Data synthesis
We planned to use the ﬁxed-effect model in RevMan 2014
for meta-analyses (as per Cochrane Neonatal recommendations).
Where substantial heterogeneity existed, we planned to examine
the potential causes in subgroup and sensitivity analyses.
Subgroup analysis and investigation of heterogeneity
We planned to undertake the following subgroup analysis:
• very preterm (< 32 weeks) infants (versus infants born > 32
weeks).
Sensitivity analysis
We planned to undertake sensitivity analyses to determine if the
ﬁndings are affected by including only studies of adequatemethod-
ology (low risk of bias), deﬁned as adequate randomisation and al-
location concealment, blinding of intervention and measurement,
and < 10% loss to follow-up.
’Summary of findings’ table
We planned to assess the quality of evidence for the main compar-
isons at the primary outcomes level using the GRADE approach,
as outlined in the GRADE handbook (Guyatt 2011a). Two re-
view authors planned to independently assess the quality of the
evidence for outcomes identiﬁed as critical or important for clin-
ical decision-making (infection, death). We planned to consider
evidence from randomised controlled trials as high quality but
downgrade the evidence one level for serious (or two levels for
very serious) limitations based upon the following: design (risk of
bias), consistency across studies, directness of the evidence, preci-
sion of estimates and presence of publication bias (Appendix 2).
We planned to use the GRADEpro Guideline Development Tool
to create a ‘Summary of ﬁndings’ table to report the quality of the
evidence (GRADEpro GDT).
R E S U L T S
Description of studies
We did not identify any studies or ongoing trials that met our
inclusion criteria (Figure 1).
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Figure 1. Study flow diagram.
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Included studies
We did not identify any eligible trials.
Excluded studies
We excluded one RCT of different durations of placement of um-
bilical venous catheters in newborn infants (Butler-O’Hara 2006).
Risk of bias in included studies
We did not identify any eligible trials.
Effects of interventions
We did not identify any eligible trials.
D I S C U S S I O N
Summary of main results
Given that deciding the duration of placement of peripherally in-
serted central catheters (PICCs) is a common and important clin-
ical dilemma that may affect important outcomes for preterm or
sick newborn infants, and that substantial uncertainty and varia-
tion in practice exists with regard to early planned PICC removal
versus expectant management, it is concerning that this question
has not yet been addressed in any randomised controlled trials.
Overall completeness and applicability of
evidence
In the absence of such trial data, decisions regarding the dwell
time of PICCs in infants may continue to rely on the ﬁndings of
observational studies. These studies, however, have not provided
consistent evidence about the effect of duration of PICC place-
ment on the risk of invasive infection and other complications in
newborn infants. Any reported associations, moreover, are likely
to be confounded because infants who are smaller, less mature,
sicker and receiving more intensive and invasive support are both
more likely to acquire bloodstream infection and to have a PICC
in situ (Smith 2008; Sengupta 2010; Wong 2012; Milstone 2013;
Greenberg 2015). The variation in policy and practice between
neonatal units and clinicians reﬂects the ongoing uncertainty with
which the available observational data are viewed (Sharpe 2013;
Taylor 2014).
Potential biases in the review process
Although we conducted a comprehensive search, including con-
ference proceedings, we cannot exclude fully the possibility that
other published (but not indexed) or unpublished trials exist.
Agreements and disagreements with other
studies or reviews
There appear to be limited data to inform decisions about the op-
timal duration of placement of PICCs (and other central venous
catheters (CVCs)) in other populations of patients. Guidelines
published by the Healthcare Infection Control Practices Advisory
Committee recommend that PICCs should be removed when no
longer essential, but do not recommend routine removal and re-
placement to prevent catheter-related infections, and do not make
any recommendations about dwell time (O’Grady 2011).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There are no randomised controlled trials of this intervention to
inform policy or practice. Some, but not all, cohort studies suggest
that early PICC removal is associated with a lower risk of persistent
infection but these ﬁndings were not systematically reviewed and
should be interpreted with caution because of biases inherent in
the study design.
Implications for research
Given the potential for beneﬁt and harm to be associated with the
duration of placement of a PICC in a newborn infant, a pragmatic
randomised controlled trial of early removal (with replacement if
required) versus expectant management may be warranted. Such
a trial might primarily address the effect on the risk of catheter-
related bloodstream infections (deﬁned using established and val-
idated criteria) in those groups of infants with anticipated pro-
longed duration of PICC use (such as extremely preterm infants or
infants with severe growth-restriction). Trials with sufﬁcient power
to detect reliably and precisely effects on the risk of infection and
other catheter- and infection-related complications would need to
be large, multi-centre and pragmatic in design.
A C K N OW L E D G E M E N T S
Ms Kath Wright for developing the electronic search strategy.
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